TG
EPZM

TCW Group’s Epizyme, Inc EPZM Stock Holding History

TCW Group’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-18,894
Closed -$229K – 700
2016
Q1 		$229K Sell
18,894
-1,820
-9% -$18.4K ﹤0.01% 673
2015
Q4 		$332K Buy
20,714
+1,220
+6% +$18.1K ﹤0.01% 661
2015
Q3 		$251K Sell
19,494
-6,100
-24% -$123K ﹤0.01% 686
2015
Q2 		$614K Hold
25,594
– – ﹤0.01% 603
2015
Q1 		$481K Buy
+25,594
New +$529K ﹤0.01% 733

Other funds holding EPZM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

TCW Group's EPZM Position: Q2 2016 in Review

TCW Group sold out of Epizyme, Inc (EPZM) in Q2 2016, closing a stake of 18,894 shares — an estimated $229K sold.

TCW Group first reported a position in EPZM in Q1 2015 and held it in 5 quarters. The position peaked at $614K in Q2 2015. 99 funds tracked by Wall St. Rank hold EPZM as of Q2 2016.

  • TCW Group reported no remaining Epizyme, Inc position as of Q2 2016 after selling out during the quarter.
  • TCW Group sold 18,894 Epizyme, Inc shares in Q2 2016, an estimated $229K.
  • TCW Group first reported a position in Epizyme, Inc in Q1 2015 and held it in 5 quarters.
  • TCW Group's Epizyme, Inc position peaked at $614K in Q2 2015.
  • 99 funds tracked by Wall St. Rank held Epizyme, Inc as of Q2 2016.

Based on TCW Group's 13F filing for Q2 2016, filed 12 Aug 2016.